Latest News On NIH

Latest California Healthline Stories

KHN’s ‘What The Health?’: Live from D.C. With Rep. Donna Shalala

President Donald Trump’s proposed budget includes billions of dollars in health spending cuts, Congress gets back to work on surprise medical bills, and health care remains a top issue for the 2020 Democratic presidential candidates. Rep. Donna Shalala (D-Fla.), a former Health and Human Services secretary, joins the panel at a special taping before a live audience in Washington, D.C. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more.

Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers

A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.

FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?

The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.

KHN’s ‘What The Health?’: Fetal Tissue Research Is Latest Flashpoint In Abortion Debate

Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the Trump administration’s efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Biden’s support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.